Alzheimer’s Clinical Trials Consortium – Down Syndrome
Accelerating Alzheimer’s Research in Down Syndrome
We connect world-class clinical trials with the DS community to advance prevention and treatment of Alzheimer’s Disease.
Alzheimer’s disease in Down syndrome
People with Down syndrome are living healthier, longer and more independent lives than ever before. With this increased lifespan, we are finding that there is an increased risk for developing Alzheimer’s disease. There is an urgent need to find therapies that treat or prevent AD in people with Down syndrome. ACTC-DS aims to bring the latest and most innovative AD therapies to the DS population.
Make a Difference in Alzheimer’s Disease Research in Down Syndrome
Sites
23
Publications
+50
About
ACTC-DS infrastructure includes expertise in study design and conduct, and full clinical trial management capability through our coordinating center and network of trial sites.
Trials
We collaborate with leading investigators to develop and advance clinical trials focused on Alzheimer’s disease in Down syndrome, spanning early detection through later-stage interventions.
Sites
Our sites unite expert investigators across the US and Europe to advance Alzheimer’s disease research in the Down syndrome community.
TRC-DS reaches 450+ participants enrolled!
Explore ACTC-DS Studies and Clinical Trials
Discover ongoing research initiatives across our international network.
Learn About Our Trials
Research Starts With Partnership: Progress in Alzheimer’s disease research depends on individuals with Down syndrome, families, caregivers, and researchers working together.
For Researchers:
Join the ACTC-DS Research Network.
Collaborate with leading investigators advancing Alzheimer’s disease research in Down syndrome.